354 related articles for article (PubMed ID: 30062580)
1. Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.
Wilkie MD; Fraser HM; Raja H
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2515-2521. PubMed ID: 30062580
[TBL] [Abstract][Full Text] [Related]
2. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux.
McGlashan JA; Johnstone LM; Sykes J; Strugala V; Dettmar PW
Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):243-51. PubMed ID: 18506466
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
5. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it.
Lieder A; Issing W
Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545
[No Abstract] [Full Text] [Related]
6. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.
Reimer C; Lødrup AB; Smith G; Wilkinson J; Bytzer P
Aliment Pharmacol Ther; 2016 Apr; 43(8):899-909. PubMed ID: 26909885
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
[TBL] [Abstract][Full Text] [Related]
8. Influence of age on treatment with proton pump inhibitors in patients with laryngopharyngeal reflux disease: a prospective multicenter study.
Lee YC; Lee JS; Kim SW; Kwon KH; Eun YG
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1291-5. PubMed ID: 24201320
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
[TBL] [Abstract][Full Text] [Related]
10. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
Onuchina EV; Brikova SI; Tsukanov VV
Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
[TBL] [Abstract][Full Text] [Related]
11. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
[No Abstract] [Full Text] [Related]
12. [Diagnostic value of alginate test in gastroesophageal reflux disease].
Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
[TBL] [Abstract][Full Text] [Related]
13. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
14. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
Yuan YZ; Fang JY; Zou DW; Levinson N; Jenner B; Wilkinson J
J Dig Dis; 2016 Nov; 17(11):725-734. PubMed ID: 27622897
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux.
Zalvan CH; Hu S; Greenberg B; Geliebter J
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1023-1029. PubMed ID: 28880991
[TBL] [Abstract][Full Text] [Related]
16. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.
Pizzorni N; Ambrogi F; Eplite A; Rama S; Robotti C; Lechien J; Schindler A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2533-2542. PubMed ID: 35032204
[TBL] [Abstract][Full Text] [Related]
17. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
18. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
[TBL] [Abstract][Full Text] [Related]
19. [Alginate improves symptom control].
Siegmund-Schultze N
MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
[No Abstract] [Full Text] [Related]
20. Effects of Proton Pump Inhibitor Therapy for Laryngopharyngeal Reflux on Posttreatment Symptoms and Hypopharyngeal pH.
Waxman J; Yalamanchali S; Valle ES; Pott T; Friedman M
Otolaryngol Head Neck Surg; 2014 Jun; 150(6):1010-7. PubMed ID: 24647643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
